US Stock MarketDetailed Quotes

Avanos Medical (AVNS)

Watchlist
  • 24.620
  • -0.040-0.16%
Close Apr 27 16:00 ET
  • 24.620
  • 0.0000.00%
Post 17:13 ET
1.15BMarket Cap-15.68P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Avanos Medical (AVNS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-25.82%74.7M
-51.30%28.2M
-39.13%14M
-75.54%6.8M
421.25%25.7M
210.80%100.7M
355.91%57.9M
-20.96%23M
1,169.23%27.8M
-17.65%-8M
Net income from continuing operations
81.41%-72.9M
99.67%-1.3M
-132.56%-1.4M
-4,366.67%-76.8M
833.33%6.6M
-534.47%-392.1M
-3,883.81%-397.3M
216.22%4.3M
102.64%1.8M
-80.00%-900K
Operating gains losses
675.00%9.3M
350.00%3.6M
5,300.00%5.4M
--100K
-33.33%200K
-98.35%1.2M
-98.88%800K
--100K
--0
--300K
Depreciation and amortization
-14.51%38.9M
-10.81%9.9M
-19.66%9.4M
-11.50%10M
-15.79%9.6M
-1.30%45.5M
-3.48%11.1M
6.36%11.7M
-1.74%11.3M
-5.79%11.4M
Change In working capital
-42.29%20.2M
-45.56%24.5M
-178.38%-2.9M
-181.93%-6.8M
124.55%5.4M
294.44%35M
862.71%45M
-82.04%3.7M
161.94%8.3M
-13.99%-22M
-Change in receivables
568.18%30.9M
2,600.00%8.1M
109.09%700K
59.46%-3M
206.10%25.1M
-116.92%-6.6M
-96.67%300K
-169.37%-7.7M
-1.37%-7.4M
-68.70%8.2M
-Change in inventory
-99.49%200K
-93.76%2.8M
-126.32%-500K
-6.45%-3.3M
125.53%1.2M
729.79%39M
297.35%44.9M
-70.77%1.9M
31.11%-3.1M
45.35%-4.7M
-Change in prepaid assets
-90.60%1.4M
-58.33%3M
-202.70%-3.8M
-54.76%1.9M
250.00%300K
176.02%14.9M
136.36%7.2M
1,950.00%3.7M
121.05%4.2M
86.67%-200K
-Change in payables and accrued expense
0.00%-12.3M
243.24%10.6M
-87.93%700K
-116.44%-2.4M
16.21%-21.2M
70.78%-12.3M
-15.63%-7.4M
81.25%5.8M
517.14%14.6M
28.53%-25.3M
Cash from discontinued investing activities
Operating cash flow
-25.82%74.7M
-51.30%28.2M
-39.13%14M
-75.54%6.8M
421.25%25.7M
210.80%100.7M
355.91%57.9M
-20.96%23M
1,169.23%27.8M
-17.65%-8M
Investing cash flow
Cash flow from continuing investing activities
-120.36%-60.6M
10.53%-6.8M
-162.50%-31.5M
-123.73%-13.2M
-355.00%-9.1M
-227.31%-27.5M
-109.38%-7.6M
75.46%-12M
9.23%-5.9M
50.00%-2M
Capital expenditure reported
-77.53%-31.6M
-43.75%-6.9M
-133.33%-7M
-86.44%-11M
-63.41%-6.7M
0.00%-17.8M
18.64%-4.8M
23.08%-3M
-47.50%-5.9M
-2.50%-4.1M
Net business purchase and sale
-240.21%-33M
-907.14%-28.2M
97.78%-200K
---2.2M
-214.29%-2.4M
-124.62%-9.7M
-107.11%-2.8M
---9M
--0
--2.1M
Net other investing changes
--4M
--28.3M
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-120.36%-60.6M
10.53%-6.8M
-162.50%-31.5M
-123.73%-13.2M
-355.00%-9.1M
-227.31%-27.5M
-109.38%-7.6M
75.46%-12M
9.23%-5.9M
50.00%-2M
Financing cash flow
Cash flow from continuing financing activities
24.64%-37M
90.15%-2.7M
87.50%-2M
36.00%-3.2M
-4,057.14%-29.1M
47.88%-49.1M
76.11%-27.4M
-134.26%-16M
-21.95%-5M
96.83%-700K
Net issuance payments of debt
-2.38%-34.4M
91.21%-2.4M
82.58%-2.3M
-60.00%-2.4M
-425.00%-27.3M
48.07%-33.6M
71.74%-27.3M
-124.00%-13.2M
0.00%-1.5M
138.89%8.4M
Net common stock issuance
74.22%-3.3M
-200.00%-300K
--0
77.14%-800K
75.82%-2.2M
32.98%-12.8M
98.39%-100K
98.91%-100K
-34.62%-3.5M
-727.27%-9.1M
Proceeds from stock option exercised by employees
-36.36%700K
--0
-50.00%300K
--0
-20.00%400K
-15.38%1.1M
--0
-33.33%600K
--0
-16.67%500K
Net other financing activities
----
----
----
----
----
67.52%-3.8M
--0
---3.3M
--0
---500K
Cash from discontinued financing activities
Financing cash flow
24.64%-37M
90.15%-2.7M
87.50%-2M
36.00%-3.2M
-4,057.14%-29.1M
47.88%-49.1M
76.11%-27.4M
-134.26%-16M
-21.95%-5M
96.83%-700K
Net cash flow
Beginning cash position
22.81%107.7M
-20.79%70.5M
-2.06%90.3M
27.97%97M
22.81%107.7M
-31.32%87.7M
-16.90%89M
12.71%92.2M
-20.79%75.8M
-31.32%87.7M
Current changes in cash
-195.02%-22.9M
-18.34%18.7M
-290.00%-19.5M
-156.80%-9.6M
-16.82%-12.5M
159.95%24.1M
209.05%22.9M
-118.59%-5M
228.03%16.9M
67.48%-10.7M
Effect of exchange rate changes
221.95%5M
114.29%600K
-116.67%-300K
680.00%2.9M
250.00%1.8M
-2,150.00%-4.1M
-362.50%-4.2M
212.50%1.8M
28.57%-500K
-233.33%-1.2M
End cash Position
-16.62%89.8M
-16.62%89.8M
-20.79%70.5M
-2.06%90.3M
27.97%97M
22.81%107.7M
22.81%107.7M
-16.90%89M
12.71%92.2M
-20.79%75.8M
Free cash flow
-48.01%43.1M
-59.89%21.3M
-65.00%7M
-119.18%-4.2M
257.02%19M
467.81%82.9M
680.88%53.1M
-20.63%20M
431.82%21.9M
-12.04%-12.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -25.82%74.7M-51.30%28.2M-39.13%14M-75.54%6.8M421.25%25.7M210.80%100.7M355.91%57.9M-20.96%23M1,169.23%27.8M-17.65%-8M
Net income from continuing operations 81.41%-72.9M99.67%-1.3M-132.56%-1.4M-4,366.67%-76.8M833.33%6.6M-534.47%-392.1M-3,883.81%-397.3M216.22%4.3M102.64%1.8M-80.00%-900K
Operating gains losses 675.00%9.3M350.00%3.6M5,300.00%5.4M--100K-33.33%200K-98.35%1.2M-98.88%800K--100K--0--300K
Depreciation and amortization -14.51%38.9M-10.81%9.9M-19.66%9.4M-11.50%10M-15.79%9.6M-1.30%45.5M-3.48%11.1M6.36%11.7M-1.74%11.3M-5.79%11.4M
Change In working capital -42.29%20.2M-45.56%24.5M-178.38%-2.9M-181.93%-6.8M124.55%5.4M294.44%35M862.71%45M-82.04%3.7M161.94%8.3M-13.99%-22M
-Change in receivables 568.18%30.9M2,600.00%8.1M109.09%700K59.46%-3M206.10%25.1M-116.92%-6.6M-96.67%300K-169.37%-7.7M-1.37%-7.4M-68.70%8.2M
-Change in inventory -99.49%200K-93.76%2.8M-126.32%-500K-6.45%-3.3M125.53%1.2M729.79%39M297.35%44.9M-70.77%1.9M31.11%-3.1M45.35%-4.7M
-Change in prepaid assets -90.60%1.4M-58.33%3M-202.70%-3.8M-54.76%1.9M250.00%300K176.02%14.9M136.36%7.2M1,950.00%3.7M121.05%4.2M86.67%-200K
-Change in payables and accrued expense 0.00%-12.3M243.24%10.6M-87.93%700K-116.44%-2.4M16.21%-21.2M70.78%-12.3M-15.63%-7.4M81.25%5.8M517.14%14.6M28.53%-25.3M
Cash from discontinued investing activities
Operating cash flow -25.82%74.7M-51.30%28.2M-39.13%14M-75.54%6.8M421.25%25.7M210.80%100.7M355.91%57.9M-20.96%23M1,169.23%27.8M-17.65%-8M
Investing cash flow
Cash flow from continuing investing activities -120.36%-60.6M10.53%-6.8M-162.50%-31.5M-123.73%-13.2M-355.00%-9.1M-227.31%-27.5M-109.38%-7.6M75.46%-12M9.23%-5.9M50.00%-2M
Capital expenditure reported -77.53%-31.6M-43.75%-6.9M-133.33%-7M-86.44%-11M-63.41%-6.7M0.00%-17.8M18.64%-4.8M23.08%-3M-47.50%-5.9M-2.50%-4.1M
Net business purchase and sale -240.21%-33M-907.14%-28.2M97.78%-200K---2.2M-214.29%-2.4M-124.62%-9.7M-107.11%-2.8M---9M--0--2.1M
Net other investing changes --4M--28.3M--------------------------------
Cash from discontinued investing activities
Investing cash flow -120.36%-60.6M10.53%-6.8M-162.50%-31.5M-123.73%-13.2M-355.00%-9.1M-227.31%-27.5M-109.38%-7.6M75.46%-12M9.23%-5.9M50.00%-2M
Financing cash flow
Cash flow from continuing financing activities 24.64%-37M90.15%-2.7M87.50%-2M36.00%-3.2M-4,057.14%-29.1M47.88%-49.1M76.11%-27.4M-134.26%-16M-21.95%-5M96.83%-700K
Net issuance payments of debt -2.38%-34.4M91.21%-2.4M82.58%-2.3M-60.00%-2.4M-425.00%-27.3M48.07%-33.6M71.74%-27.3M-124.00%-13.2M0.00%-1.5M138.89%8.4M
Net common stock issuance 74.22%-3.3M-200.00%-300K--077.14%-800K75.82%-2.2M32.98%-12.8M98.39%-100K98.91%-100K-34.62%-3.5M-727.27%-9.1M
Proceeds from stock option exercised by employees -36.36%700K--0-50.00%300K--0-20.00%400K-15.38%1.1M--0-33.33%600K--0-16.67%500K
Net other financing activities --------------------67.52%-3.8M--0---3.3M--0---500K
Cash from discontinued financing activities
Financing cash flow 24.64%-37M90.15%-2.7M87.50%-2M36.00%-3.2M-4,057.14%-29.1M47.88%-49.1M76.11%-27.4M-134.26%-16M-21.95%-5M96.83%-700K
Net cash flow
Beginning cash position 22.81%107.7M-20.79%70.5M-2.06%90.3M27.97%97M22.81%107.7M-31.32%87.7M-16.90%89M12.71%92.2M-20.79%75.8M-31.32%87.7M
Current changes in cash -195.02%-22.9M-18.34%18.7M-290.00%-19.5M-156.80%-9.6M-16.82%-12.5M159.95%24.1M209.05%22.9M-118.59%-5M228.03%16.9M67.48%-10.7M
Effect of exchange rate changes 221.95%5M114.29%600K-116.67%-300K680.00%2.9M250.00%1.8M-2,150.00%-4.1M-362.50%-4.2M212.50%1.8M28.57%-500K-233.33%-1.2M
End cash Position -16.62%89.8M-16.62%89.8M-20.79%70.5M-2.06%90.3M27.97%97M22.81%107.7M22.81%107.7M-16.90%89M12.71%92.2M-20.79%75.8M
Free cash flow -48.01%43.1M-59.89%21.3M-65.00%7M-119.18%-4.2M257.02%19M467.81%82.9M680.88%53.1M-20.63%20M431.82%21.9M-12.04%-12.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.72%
Sample Name
Sample Code
 +8.47%
Sample Name
Sample Code
 +7.98%
4
VanEck Oil Services ETF
OIH
+5.58%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.68%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.58%
Sample Name
Sample Code
 +6.89%
Sample Name
Sample Code
 +5.36%
4
Chagee Holdings
CHA
+3.18%
5
Qifu Technology
QFIN
+0.60%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -